Paul M. Bisaro

President and Chief Executive Officer and Director

Paul M. Bisaro

President and Chief Executive Officer and Director

Paul M. Bisaro has served as President and Chief Executive Officer and a member of the Company’s Board since March 2017. With 25 years of generic and branded pharmaceutical experience, Mr. Bisaro is an accomplished global business leader who brings a successful record of leading operational execution and corporate transformation, resulting in company growth. He previously served as Executive Chairman of Allergan, plc (formerly Actavis, plc), President and CEO of Actavis (formerly Watson Pharmaceuticals, Inc.) and Chairman of the Board. Prior to joining Watson in 2007, Mr. Bisaro was President, Chief Operating Officer and a member of the Board of Directors of Barr Pharmaceuticals, Inc., a global specialty pharmaceutical company (Barr), from 1999 to 2007. Between 1992 and 1999, Mr. Bisaro served as General Counsel of Barr, and from 1997 to 1999, served in various additional capacities. Prior to joining Barr, he was associated with the law firm Winston & Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds, from 1989 to 1992. He also served as a Senior Consultant with Arthur Andersen & Co. Mr. Bisaro currently serves on the Board of Directors of Allergan, Zoetis, Inc. and on the Board of Visitors of the Catholic University of America’s Columbus School of Law. He also served as Chairman of the Board of the Generic Pharmaceutical Association (GPhA) in 2010 and 2011. Mr. Bisaro received his undergraduate degree in General Studies from the University of Michigan and a Juris Doctor from Catholic University of America in Washington, D.C.

Douglas S. Boothe

President, Impax Generics Division

Douglas S. Boothe

President, Impax Generics Division

Douglas S. Boothe joined Impax as President, Generics Division in 2016. Mr. Boothe previously served as Executive Vice President and General Manager with Perrigo Company plc, where he had responsibility for U.S. Pharmaceuticals, including Generics and Specialty. Mr. Boothe also served as Chief Executive Officer of Actavis, Inc. and as Executive Vice President and Chief Operating Officer. Prior to Actavis, Mr. Boothe held various senior positions in strategic planning and business development for Alpharma Inc., Pharmacia Corporation, and Xerox Corporation, and recently served as a Board of Directors member of the Generic Pharmaceutical Association. Mr. Boothe earned a Bachelor’s degree in mechanical & aerospace engineering from Princeton University and a Master of Business Administration from the University of Pennsylvania’s Wharton School of Business.

Michael J. Nestor

President, Impax Specialty Pharma Division

Michael J. Nestor

President, Impax Specialty Pharma Division

Michael J. Nestor has served as President of our Specialty Pharma Division since 2008. Before joining us, he was Chief Operating Officer of Piedmont Pharmaceuticals, a specialty pharmaceutical company, from 2007 to 2008. Prior to Piedmont, Mr. Nestor was CEO of NanoBio, a startup biopharmaceutical company from 2004 to 2006, prior to which he was employed by Alpharma, initially as President of its generic pharmaceutical business and later as President of its branded pharmaceutical business. Before Alpharma, he was President, International business at Banner Inc., a global contract manufacturing concern. Prior to Banner, Mr. Nestor spent 16 years at Lederle Laboratories/Wyeth holding positions of increasing responsibility, including Vice President, Cardiovascular business, Vice President/General Manager of Lederle-Praxis Biologics, and Vice President of Wyeth-Lederle Vaccines and Pediatrics. Mr. Nestor has a Bachelor’s degree in Business Administration from Middle Tennessee State University and a Master of Business Administration from Pepperdine University.

Donna M. Hughes

Senior Vice President, Human Resources

Donna M. Hughes

Senior Vice President, Human Resources

Donna M. Hughes joined Impax in 2015 as Senior Vice President of our Human Resources group. Ms. Hughes has more than 20 years of legal and human resources experience and oversees all of Impax’s human resource functions. Previously, she was with Actavis, where she was Vice President, Labor and Employment, and a member of Actavis’ Global Leadership Team and Human Resources Leadership Team. She was responsible for the management of all labor and employment law matters company-wide, including employment litigation, benefits, immigration, acquisition due diligence, post-merger integration, and global human resources issues. Prior to joining Actavis, Ms. Hughes served as Director and Assistant General Counsel for Circuit City Stores, Inc., where she managed the company’s employment law department. She spent seven years in private practice and worked at New Jersey law firms Pitney, Hardin, LLP and St. John & Wayne, LLC. She has previously served as adjunct faculty for Rutgers University School of Management, Rutgers University’s Political Science Department, and Seton Hall University School of Law. She received her Juris Doctorate from Rutgers University School of Law-Newark and her Bachelor’s degree from Rutgers College, Rutgers University.

Jeffrey D. Nornhold

Senior Vice President, Technical Operations

Jeffrey D. Nornhold

Senior Vice President, Technical Operations

Jeffrey D. Nornhold has served as our Senior Vice President of Technical Operations since 2014, and is responsible for the Company’s manufacturing, supply chain, quality and technical operations. Mr. Nornhold previously served as the Senior Vice President, Global Quality Affairs since 2011, and was responsible for establishing the foundation for a sustainable quality and compliance program. Mr. Nornhold joined Impax from Watson Pharmaceuticals, Inc., (now Actavis) where he was the Vice President, Quality Operations – International, and was responsible for manufacturing sites outside of the U.S. for both dosage and active pharmaceutical ingredients. While at Watson, he also served as Vice President U.S. Quality Operations leading the development and execution of quality initiatives for all U.S. sites. Prior to joining Watson in 2000, he held numerous leadership positions within the pharmaceutical industry. He earned a Bachelor’s degree in chemistry from Bowling Green State University and a Master of Business Administration from the University of Southern California Marshall School of Business.

Deborah M. Penza

Senior Vice President, Chief Compliance Officer

Deborah M. Penza

Senior Vice President, Chief Compliance Officer

Deborah M. Penza joined Impax in 2015 as Senior Vice President, Chief Compliance Officer. Ms. Penza has more than 20 years of experience as both a consultant and a compliance professional implementing and operating compliance programs in the healthcare industry. She is responsible for the development, implementation and oversight of Impax’s corporate compliance program. Previous to joining Impax, she was with Actavis as the Company’s Chief Compliance Officer. Prior to Actavis, Ms. Penza served as the Vice President, Corporate Compliance for Elan Corporation, plc, where she led the company’s global ethics and compliance program. Before joining Elan, she was a Vice President of Strategic Management Systems, Inc., where she developed and implemented compliance programs for healthcare clients and provided guidance on compliance program management. She received her Juris Doctorate from the George Mason University School of Law, and she possesses a Master of Arts from The George Washington University. She received her Bachelor’s degree from Florida Atlantic University.

Bryan M. Reasons

Senior Vice President, Finance and Chief Financial Officer

Bryan M. Reasons

Senior Vice President, Finance and Chief Financial Officer

Bryan M. Reasons has served as our Senior Vice President, Finance and Chief Financial Officer since 2012. Prior to joining Impax, Mr. Reasons served as Vice President, Finance and as Vice President, Risk Management and General Auditor, at Cephalon, Inc., a biopharmaceutical company. Following the acquisition of Cephalon by Teva Pharamaceutical Industries Ltd., he served as Vice President, Finance of Teva. Prior to joining Cephalon, Mr. Reasons held various financial management positions at DuPont and served as senior manager at PricewaterhouseCoopers LLP. Mr. Reasons has a Bachelor’s degree in accounting from Pennsylvania State University and a Master of Business Administration from Widener University and is a certified public accountant.

Mark A. Schlossberg

Senior Vice President and General Counsel

Mark A. Schlossberg

Senior Vice President and General Counsel

Mark A. Schlossberg has served as our Senior Vice President, General Counsel and Corporate Secretary since 2011. Prior to joining us, he served as Vice President, Associate General Counsel of Amgen Inc.. Prior to joining Amgen, he held legal and business positions at Medtronic, Inc., and legal positions at Diageo plc, RJR Nabisco, Inc. and Mudge Rose Guthrie Alexander & Ferdon. He earned a Bachelor of Sciences in business administration, and finance from the University of Southern California and a Juris Doctor degree from Emory University.